Dyslipidemia, Insulin Sensitivity Indices, MetabolicRisk Factors, And Anti Müllerian HormoneLevels In Egyptian Women With Polycystic Ovary Syndrome

Anti-Mullerian hormone, a marker for metformin therapy efficacy in polycystic ovarian syndrome: a pilot study on an Egyptian population

Anti-Mullerian Hormone Serum Concentrationsin Women with Polycystic Ovaries and Normoovulatory Women of Reproductive Age

The Role of Serum Adiponectin Levels in Women with Polycystic Ovarian Syndrome

Polycystic Ovary Syndrome Phenotypes among Infertile Women in Zagazig University Hospitals

Relation between Anti-Müllerian Hormone with Antral Follicle Count and Ovarian Volume in Polycystic Ovary Syndrome

Anti-Mullerian Hormone as A new Marker for Diagnosis of Poly Cystic Ovary Syndrome

GHRELIN IN POLYCYSTIC OVARIAN SYNDROME WITH AND WITHOUT DIABETES MELLITUS IN EGYPTIAN POPULATION

Copeptin and Obestatin Levels in Polycystic Ovary women and their Relation to Obesity, insulin metabolism and Cardiovascular diseases

Anti-Mullerian Hormone: An Indicator for the Severity of Polycystic Ovarian Syndrome